<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005">
<channel xmlns:cfi="http://www.microsoft.com/schemas/rss/core/2005/internal" cfi:lastdownloaderror="None">
<title cf:type="text"><![CDATA[Progress in Biochemistry and Biophysics -->Special Topic: COVID-19 Research]]></title>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Analysis of The Impact of SARS-CoV-2 Variants on Global Epidemic Prevention and Control]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220098]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to international public health. The SARS-COV-2 gene continues to mutate in COVID-19 outbreaks. Mutation mainly manifests in 3 forms: point mutation, gene recombination and epigenetic modification. Viral mutations are driven by multiple factors, with mutation rates modulated at 3 levels, the nature of virus, host-virus interactions and natural selection. Therefore, it is particularly important to strengthen the monitoring of the global novel coronavirus genome and the protection of immunosuppressed populations. In the early stage of virus evolution, the mutant strains exhibit greater transmissibility and less virulence than the wild-type strain, although 5 variants of concern (VOCs) showed different stability, transmission capacity, adaptability and pathogenicity. So physical interventions need to be further strengthened. As herd immunity is established, novel mutant strains tend to mutate against vaccines and antibodies. In that case, VOCs, especially the prevailing Omicron variant, bring challenges to the prevention and control of COVID-19 worldwide. The existing and potential prevention, diagnosis and treatment approaches for COVID-19 were summarized. In the vaccination part, the protective efficacy of COVID-19 vaccine against VOCs and the factors influencing the efficacy of COVID-19 vaccine were analyzed. In the detection part, the detection methods based on nucleic acid, antigen and antibody were summarized in order to satisfy the requirements for point-of-care testing and timely recognition of novel variants. And in the treatment part, the potential therapeutic drugs and targets of SARS-CoV-2 were summarized. Drug targets are generally divided into extracellular targets and intracellular targets. In general, this review proposes possible countermeasures by analyzing the impact of mutations on global epidemic prevention and control, hoping to provide theoretical basis for possible large-scale epidemic prevention and control in the future.]]></description>
<pubDate>2022/10/21 0:00:00</pubDate>
<category><![CDATA[Special Topic: COVID-19 Research]]></category>
<author><![CDATA[HU Er-Ya,ZHOU Min,ZENG Wen-Hui,LUO Yan,YAN Zi-Dong and MA Jian]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>HU Er-Ya,ZHOU Min,ZENG Wen-Hui,LUO Yan,YAN Zi-Dong and MA Jian</atom:name>
</atom:author>
<guid><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220098]]></guid><cfi:id>5</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Progress in Research of COVID-19 Based on Proteomics Techniques]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220029]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus is highly contagious and spreads rapidly, posing a serious threat to the health and safety of people around the world. Proteomics technology has the characteristics of high throughput and high sensitivity, and plays an important role in biomarker discovery, molecular mechanism research, and therapeutic target research. Proteomics technology has been widely used in the research of COVID-19. Herein, this study provides a comprehensive review of the research progress of COVID-19 based on proteomics techniques. In section 1, the genome structure of SARS-CoV-2 and the process of SARS-CoV-2 infecting host cells were summarized. In section 2, the currently commonly used mass spectrometry (MS)-based proteomics techniques including liquid chromatography (LC)-MS and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) MS were reviewed. In section 3, the application progress in the research of precise diagnosis, molecular mechanism and drug therapy targets of COVID-19 based proteomics technology was highlighted. Proteomics have been employed in biomedical research to uncover biomarkers associated with COVID-19, it also provides a comprehensive snapshot of virus-induced changes to the host following infection, invasion, persistence, and pathogenesis and can prime the identification of novel therapeutic targets for preventing or lessening disease severity. In section 4, the future development direction of proteomics was prospected. It’s hoped that this review can help to promote the development of proteomics technology in the precise diagnosis and treatment of diseases.]]></description>
<pubDate>2022/10/21 0:00:00</pubDate>
<category><![CDATA[Special Topic: COVID-19 Research]]></category>
<author><![CDATA[LIU Xiang,GONG Peng-Yun,TANG Min,HU Hong-Ke,ZHANG Yong-Biao and LIU Chao]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>LIU Xiang,GONG Peng-Yun,TANG Min,HU Hong-Ke,ZHANG Yong-Biao and LIU Chao</atom:name>
</atom:author>
<guid><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220029]]></guid><cfi:id>4</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Effects of SARS-CoV-2 Membrane Glycoprotein on Host Pre-mRNA 3" Processing]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220217]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b> To investigate the effect of SARS-CoV-2 membrane protein on the processing of the 3" untranslated region (UTR) of the mRNA precursor (pre-mRNA) in host cells.<b>Methods</b> Based on the cell model of human lung epithelial cells A549, over-expression of the SARS-CoV-2 membrane protein was performed. The RNA-Seq high-throughput sequencing technique and bioinformatics methods was employed to analyze the systematic characterization of alternative polyadenylation (APA) events in host cells. Genes with significant APA events were uploaded to the Metascape database for functional enrichment analysis. In addition, alternative 3"UTR length of genes with APA events was verified by RT-qPCR. Then the target protein expression level was detected by Western blot.<b>Results</b> A total of 813 genes that were significant dynamic APA events in host cells that over-expressed SARS-CoV-2 membrane protein. These genes were enriched in cell biologicial processes such as the mitotic cell cycle and regulation of cellular response to stress. We further screened <i>AKT1</i>, which encodes a critical regulator involved in the above biological process, showing a 3"UTR lengthening in IGV software. RT-qPCR verified the trend of 3"UTR length changes of <i>AKT1</i>. Western blot showed the increased level of phosphorylated AKT1 protein in over-expressed group of M protein.<b>Conclusion</b> SARS-CoV-2 membrane protein potentially affects the 3" processing of host pre-mRNAs. <i>AKT1</i>, which is involved in a variety of viral biological processes, with 3"UTR lengthening, and its protein function was activated intracellularly.]]></description>
<pubDate>2022/10/21 0:00:00</pubDate>
<category><![CDATA[Special Topic: COVID-19 Research]]></category>
<author><![CDATA[OUYANG Xin,ZENG Xian-Yan,GU Bin,LOU Zhe-Qi,HUANG Jin,TAN Zheng-Zong,YU Qian,CHE Yu,QIAN Yu-Zhou and ZHU Yong]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>OUYANG Xin,ZENG Xian-Yan,GU Bin,LOU Zhe-Qi,HUANG Jin,TAN Zheng-Zong,YU Qian,CHE Yu,QIAN Yu-Zhou and ZHU Yong</atom:name>
</atom:author>
<guid><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220217]]></guid><cfi:id>3</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Transmission Model of COVID-19 Pandemic Based on Infectivity and Immunity]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220213]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b> Many mutant strains of SARS-CoV-2 have stronger infectivity and immune escape ability. The situation of epidemic evaluation, prevention and control is serious. The aim of the present paper is to track and predict the infectious transmission of COVID-19 through a theoretical model.<b>Methods</b> Based on the grid epidemic model, this paper discussed the relationship between the duration of infection and the effect of group immunity, and on this basis, established the theoretical model of infection transmission of COVID-19. The infectivity parameter <i>A</i> and the immune effect parameter <i>B</i> are introduced to predict the daily variation curve of infection. The parameter <inline-formula></inline-formula> can be used to quantitatively compare the comprehensive infectivity of each mutant, and we also test the conjecture that the infection parameters <i>A</i> and <i>B</i> are not related to regional factors.<b>Results</b> Through the theoretical model of infection transmission of COVID-19, the infectious time was accurately predicted. By analyzing the infectivity and electrical changes of mutant strains, the internal relationship between the infectivity of mutant strains and the electrical changes of mutant residues was pointed out. The parameter changes of mutants were analyzed, and the comprehensive infectivity of each mutant was quantitatively compared. We also verified the conjecture that parameters <i>A</i> and <i>B</i> are only related to the nature of the virus itself and the coexistence of the virus and the human body, but not related to the region where the disease occurs and evaluated and compared the epidemic prevention level of each outbreak region.<b>Conclusion</b> This paper established a theoretical model of infection transmission of COVID-19, which can predict the duration of the epidemic, the number of new infections per day, and evaluate the infectivity of the virus, immune escape ability, comprehensive infectivity, and regional epidemic prevention level. It can also give some suggestions on epidemic prevention countermeasures according to the possible parameter changes caused by virus variation.]]></description>
<pubDate>2022/10/21 0:00:00</pubDate>
<category><![CDATA[Special Topic: COVID-19 Research]]></category>
<author><![CDATA[Liu Cheng-Fang,Liang Yu-Chao,Zhou Jian,Zuo Yong-Chun and Luo Liao-Fu]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>Liu Cheng-Fang,Liang Yu-Chao,Zhou Jian,Zuo Yong-Chun and Luo Liao-Fu</atom:name>
</atom:author>
<guid><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220213]]></guid><cfi:id>2</cfi:id><cfi:read>true</cfi:read></item>
<item>
<title xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="text"><![CDATA[Screening of Potential Inhibitors Against SARS-CoV-2 Based on Prescription Mining and Molecular Dynamics Simulations]]></title>
<link><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220224]]></link>
<description xmlns:cf="http://www.microsoft.com/schemas/rss/core/2005" cf:type="html"><![CDATA[<b>Objective</b> To detect the active ingredients in the traditional Chinese medicine prescription and its molecular mechanisms against SARS-CoV-2 by prescription mining and molecular dynamics simulations.<b>Methods</b> Herein, prescription mining and virtual screening of drugs were performed to screen the potential inhibitors against SARS-CoV-2. Molecular docking and molecular dynamics (MDs) simulations were further performed to explore the molecular recognition and inhibition mechanism between the potential inhibitors and SARS-CoV-2.<b>Results</b> The natural compounds library was constructed by 143 prescriptions of traditional Chinese medicine, which contained 640 natural compounds. Ten compounds were screened out from the natural compounds library. Among the 10 compounds, 23-trans-p-coumaryhormentic acid, the main active constituent of the Loquat leaf, showed the best binding affinity targeting the recognizing interface of SARS-CoV-2 S protein/ACE2. Upon binding 23-trans-p-coumaryhormentic acid, the key interactions between SARS-CoV-2 S protein and ACE2 were almost interrupted.<b>Conclusion</b> Ten compounds targeting SARS-CoV-2 S protein/ACE2 interface were screened out from natural compound library. And we inferred that 23-trans-p-coumaryhormentic acid is a potential inhibitor against SARS-CoV-2, which would contribute to the development of the antiviral drug for SARS-CoV-2.]]></description>
<pubDate>2022/10/21 0:00:00</pubDate>
<category><![CDATA[Special Topic: COVID-19 Research]]></category>
<author><![CDATA[ZHANG Xiao-Zheng,GAO Ying,LIU Yu,TAI Yang-Hao,LIANG Li-Zhong,ZHANG Yu-Long,HOU Shu-Lin and XIE Jun]]></author>
<atom:author xmlns:atom="http://www.w3.org/2005/Atom">
<atom:name>ZHANG Xiao-Zheng,GAO Ying,LIU Yu,TAI Yang-Hao,LIANG Li-Zhong,ZHANG Yu-Long,HOU Shu-Lin and XIE Jun</atom:name>
</atom:author>
<guid><![CDATA[http://www.pibb.ac.cn/pibben/article/abstract/20220224]]></guid><cfi:id>1</cfi:id><cfi:read>true</cfi:read></item>
</channel>
</rss>